We'd like to offer you the job doxepin structure A number of analysts have recently weighed in on NYT shares. Analysts at Zacks reiterated a “neutral” rating on shares of New York Times (NYSE:NYT) in a research note to investors on Wednesday, August 14th. They now have a $13.00 price target on the stock. On a related note, analysts at Barclays Capital downgraded shares of New York Times (NYSE:NYT) from an “overweight” rating to an “equal weight” rating in a research note to investors on Thursday, July 11th. They now have a $12.00 price target on the stock, up previously from $11.00. Finally, analysts at Thomson Reuters/Verus downgraded shares of New York Times (NYSE:NYT) from a “buy” rating to a “hold” rating in a research note to investors on Monday, July 8th.
|